Anticoagulant News and Research

RSS
Steady increase in Low Molecular Weight Heparin use for blood clots: Study

Steady increase in Low Molecular Weight Heparin use for blood clots: Study

Kowa announces data of LIVALO vs. Crestor on pharmacodynamics of warfarin

Kowa announces data of LIVALO vs. Crestor on pharmacodynamics of warfarin

New guidelines for travellers to avoid DVT on long flights

New guidelines for travellers to avoid DVT on long flights

New blood-thinning drugs likely to replace Coumadin for patients with non-valvular AF

New blood-thinning drugs likely to replace Coumadin for patients with non-valvular AF

New ACCP guidelines address DVT/PE risk factors for long-distance travel

New ACCP guidelines address DVT/PE risk factors for long-distance travel

New drug might effectively prevent clot-related strokes in patients with AF

New drug might effectively prevent clot-related strokes in patients with AF

FDA intends to grant Priority Review designation for ThromboGenics' ocriplasmin

FDA intends to grant Priority Review designation for ThromboGenics' ocriplasmin

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

Johnson & Johnson fourth quarter sales increase 3.9% to $16.3 billion

First study to elucidate how statins reduce activation of abnormal blood clotting

First study to elucidate how statins reduce activation of abnormal blood clotting

ThromboGenics submits ocriplasmin BLA with FDA to treat symptomatic VMA

ThromboGenics submits ocriplasmin BLA with FDA to treat symptomatic VMA

Enrollment complete in ThromboGenics, BioInvent TB-402 Phase IIb trial on VTE

Enrollment complete in ThromboGenics, BioInvent TB-402 Phase IIb trial on VTE

Study evaluates use of leukocyte and platelet-rich fibrin biomaterial in heart patients

Study evaluates use of leukocyte and platelet-rich fibrin biomaterial in heart patients

Study finds underutilization of warfarin among Kentucky women with AF

Study finds underutilization of warfarin among Kentucky women with AF

ISIS-FXIRx reduces Factor XI activity without bleeding in healthy volunteers

ISIS-FXIRx reduces Factor XI activity without bleeding in healthy volunteers

Research examines novel treatment techniques for hemophilia B, VTE

Research examines novel treatment techniques for hemophilia B, VTE

New method improves accuracy of AF risk assessments

New method improves accuracy of AF risk assessments

Researchers discover new tick-borne infection

Researchers discover new tick-borne infection

Xeltis receives PEI conditional approval to initiate tissue-engineered cardiovascular graft study

Xeltis receives PEI conditional approval to initiate tissue-engineered cardiovascular graft study

The Lipitor story: Drug companies brace for losses as patents expire on this and other popular medications

The Lipitor story: Drug companies brace for losses as patents expire on this and other popular medications

FDA assigns priority-review designation for ELIQUIS NDA for stroke prevention in atrial fibrillation

FDA assigns priority-review designation for ELIQUIS NDA for stroke prevention in atrial fibrillation

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.